Felix Kratz

Probing the Cysteine-34 Position of Endogenous Serum Albumin with Thiol-Binding Doxorubicin Derivatives. Improved Efficacy of an Acid-Sensitive Doxorubicin Derivative with Specific Albumin-Binding Properties Compared to That of the Parent Compound

Felix Kratz, André Warnecke, Karin Scheuermann et al. · Journal of Medicinal Chemistry · 2002 · 271 citations

The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.

Felix Kratz, M. Hartmann, Bernhard K. Keppler et al. · Journal of Biological Chemistry · 1994 · 200 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Chemoprevention Strategy +14

A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.

Ahmed M. Mansour, Joachim Drevs, N. Esser et al. · PubMed · 2003 · 197 citations

Immunology, Malignant Melanoma, Matrix Metalloproteinase 2 +19

A Novel Macromolecular Prodrug Concept Exploiting Endogenous Serum Albumin as a Drug Carrier for Cancer Chemotherapy

Felix Kratz, Ralph Müller-Driver, Inga Hofmann et al. · Journal of Medicinal Chemistry · 2000 · 160 citations

Chemoprevention Strategy, Altmetric Attention Score, Pharmacotherapy +21

Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||

Felix Kratz, Ulrich Beyer, Thomas Roth et al. · Journal of Pharmaceutical Sciences · 1998 · 152 citations